Susquehanna International Group’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-526,021
| Closed | -$1.4M | – | 6873 |
|
|
2024
Q1 | $1.4M | Buy |
526,021
+219,952
| +72% | +$585K | ﹤0.01% | 2235 |
|
|
2023
Q4 | $725K | Buy |
306,069
+160,591
| +110% | +$381K | ﹤0.01% | 3325 |
|
|
2023
Q3 | $204K | Buy |
145,478
+387
| +0.3% | +$542 | ﹤0.01% | 4525 |
|
|
2023
Q2 | $440K | Buy |
145,091
+104,906
| +261% | +$318K | ﹤0.01% | 3782 |
|
|
2023
Q1 | $251K | Buy |
+40,185
| New | +$251K | ﹤0.01% | 4613 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7016 |
|
|
2022
Q3 | – | Sell |
-12,130
| Closed | -$153K | – | 7103 |
|
|
2022
Q2 | $153K | Buy |
+12,130
| New | +$153K | ﹤0.01% | 4759 |
|
|
2022
Q1 | – | Sell |
-11,640
| Closed | -$206K | – | 6728 |
|
|
2021
Q4 | $206K | Buy |
+11,640
| New | +$206K | ﹤0.01% | 4927 |
|